Literature DB >> 19340346

Elevated N-terminal pro-brain natriuretic peptide in Mycobacterium tuberculosis pulmonary infection without myocardial dysfunction.

Simona L Bar1, Naser Sayeh, Andrew P Ignaszewski.   

Abstract

Increased levels of N-terminal pro-brain natriuretic peptide (NT pro- BNP) in infectious settings may not reflect myocardial depression. In addition to NT pro-BNP measurement, clinical assessment remains a valuable tool for diagnosis and prognosis of heart failure. A case of excessively increased NT pro-BNP level associated with Mycobacterium tuberculosis infection that was not indicative of myocardial dysfunction is described.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19340346      PMCID： PMC2706760          DOI： 10.1016/s0828-282x(09)70066-2

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN： 0828-282X            Impact factor:   5.223


  41 in total

Review 1.  Tuberculosis, lung infections, and interstitial lung disease in AJRCCM 2000.

Authors:  M J Tobin
Journal:  Am J Respir Crit Care Med       Date:  2001-11-15       Impact factor: 21.405

2.  Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension.

Authors:  Anna Fijalkowska; Marcin Kurzyna; Adam Torbicki; Grzegorz Szewczyk; Michal Florczyk; Piotr Pruszczyk; Monika Szturmowicz
Journal:  Chest       Date:  2006-05       Impact factor: 9.410

Review 3.  Effects of nitric oxide in septic shock.

Authors:  J L Vincent; H Zhang; C Szabo; J C Preiser
Journal:  Am J Respir Crit Care Med       Date:  2000-06       Impact factor: 21.405

4.  More 'malignant' than cancer? Five-year survival following a first admission for heart failure.

Authors:  S Stewart; K MacIntyre; D J Hole; S Capewell; J J McMurray
Journal:  Eur J Heart Fail       Date:  2001-06       Impact factor: 15.534

Review 5.  The B-type natriuretic peptide assay: a rapid test for heart failure.

Authors:  W Frank Peacock
Journal:  Cleve Clin J Med       Date:  2002-03       Impact factor: 2.321

6.  Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction.

Authors:  Rochus Witthaut; Christian Busch; Peter Fraunberger; Autar Walli; Dietrich Seidel; Günter Pilz; Ralph Stuttmann; Norbert Speichermann; Ljifane Verner; Karl Werdan
Journal:  Intensive Care Med       Date:  2003-08-12       Impact factor: 17.440

7.  B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure.

Authors:  Pascal de Groote; Joël Dagorn; Benoit Soudan; Nicolas Lamblin; Eugene McFadden; Christophe Bauters
Journal:  J Am Coll Cardiol       Date:  2004-05-05       Impact factor: 24.094

8.  Immunohistochemical analysis of cytokines and apoptosis in tuberculous lymphadenitis.

Authors:  Tehmina Mustafa; Stanley J Mogga; Sayoki G M Mfinanga; Odd Mørkve; Lisbet Sviland
Journal:  Immunology       Date:  2006-04       Impact factor: 7.397

9.  Nonheart failure-associated elevation of amino terminal pro-brain natriuretic peptide in the setting of sepsis.

Authors:  Simona L Bar; Elizabeth Swiggum; Lynn Straatman; Andrew Ignaszewski
Journal:  Can J Cardiol       Date:  2006-03-01       Impact factor: 5.223

10.  Marked elevations in N-terminal brain natriuretic peptide levels in septic shock.

Authors:  Gerald Chua; Lee Kang-Hoe
Journal:  Crit Care       Date:  2004-06-15       Impact factor: 9.097
View more
  1 in total

1.  Cardiopulmonary involvement in Puumala hantavirus infection.

Authors:  Johan Rasmuson; Per Lindqvist; Karen Sörensen; Magnus Hedström; Anders Blomberg; Clas Ahlm
Journal:  BMC Infect Dis       Date:  2013-10-28       Impact factor: 3.090
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.